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Abstract
Background: Smoking, physical inactivity, and poor diet, along with obesity, fasting glucose and blood pressure have been
independently associated with poorer cognitive performance. Few studies have related scales representing a combination
of these variables to multiple domains of cognitive performance. The aim of this study was to investigate the association
between overall cardiovascular health, incorporating seven components, and cognitive function.
Methods: A cross-sectional analysis employing 972 participants, from the Maine-Syracuse Longitudinal Study was
undertaken. Four health behaviors (body mass index, physical activity, diet, smoking) and three health factors (total
cholesterol, blood pressure, and fasting plasma glucose) were measured. Each was categorized according to the American
Heart Association definitions for ideal cardiovascular health, except diet, for which two food scores were calculated. A
Cardiovascular Health Score was determined by summing the number of cardiovascular metrics at ideal levels. Cognitive
function was assessed using a thorough neuropsychological test battery.
Results: Cardiovascular Health Score was positively associated with seven out of eight measures of cognitive function, with
adjustment for age, education, and gender. With further adjustment for cardiovascular and psychological variables, these
associations remained significant for Visual-Spatial Memory, Working Memory, Scanning and Tracking, Executive Function
and the Global Composite score (p,0.05 for all). Ideal levels of a number of health factors and behaviors were positively
associated with global cognitive performance.
Conclusion: Increasing cardiovascular health, indexed by a higher number of metrics at ideal levels, is associated with
greater cognitive performance. Smoking, physical activity, and diet are important components of cardiovascular health that
impact upon cognition.
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positive health behaviors such as diet or physical activity [16]. One
risk score that we are aware of, developed for the prediction of
dementia from the population-based Cardiovascular Risk Factors,
Aging, and Dementia (CAIDE) study, does include physical
activity [17]. As these health factors often co-exist with traditional
CVD risk factors and may share similar physiological pathways
[18,19], it is important to examine all these risk factors together in
relation to cognition. Improvements in the cardiovascular health
profile of individuals may help to prevent or slow age-related
cognitive decline or dementia.
The American Heart Association (AHA), in its recently released
‘Strategic Impact Goal Through 2020 and Beyond’ defined ideal
levels for four health behaviors (non-smoking, physical activity,
diet, and appropriate weight as indicated by body mass index
(BMI)), and three health factors (total cholesterol, blood pressure
(BP), and fasting blood glucose), to identify ideal cardiovascular

Introduction
Modifiable risk factors are important in the management of
cardiovascular disease (CVD) and cognitive functioning. Smoking,
physical inactivity, and poor diet, along with obesity, hypertension
and elevated blood glucose levels have been independently
associated with poorer cognitive performance and dementia in
later life [1–7]. Many models have been developed for the
prediction of diagnosis and prognosis of CVD, typically comprising traditional risk factors including age, sex, hypertension,
diabetes mellitus, smoking and blood cholesterol concentrations
[8–11]. Only a scarce number of studies have used a CVD risk
factor scale and related it to cognitive functioning. This has been
done using the Framingham risk scores (Stroke Risk Profile and
Cardiovascular Disease Risk Profile [12,13]), risk factor scales that
predict the incidence of cardiovascular events [14,15]. However
like most risk prediction models, these scales do not include
PLOS ONE | www.plosone.org
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final sample with complete wave 6 data comprised 972 individuals,
aged 23 to 98 years.

health [20]. This concept was described to promote substantial
CVD reduction by 2020. Subequently, the number of ideal
cardiovascular health metrics has been shown to be a strong
predictor of mortality from all causes [21]. These findings, along
with the work of others, has provided support for cardiovascular
health as a valid construct [22]. To date, the Coronary Artery Risk
Development in Young Adults study (CARDIA) is the sole
longitudinal study that has examined associations between ideal
cardiovascular health and cognitive function [23], showing that
ideal cardiovascular health in young adulthood is associated with
improved psychomotor speed, executive function and verbal
memory in midlife.
The AHA has highlighted the importance of targeting
cardiovascular health in order to maintain or improve brain
health [24]. World-wide, 35.6 million people were estimated to be
living with dementia in 2010, with current costs estimated at
US$604 billion per year [25]. These costs are predicted to increase
even more quickly than the future increase of prevalence.
The objective of the present study was to investigate the
combined association of these seven cardiovascular health metrics
with cognitive performance in a community-based sample of
American adults. The present study is intended to extend existing
findings by measuring five cognitive domains (indexed by multiple
cognitive tests), and two global measures of cognition. Additionally
we utilise a more detailed dietary metric than that defined by the
AHA to better reflect adherence to current national dietary
recommendations. It was hypothesised that a higher Cardiovascular Health Score (CHS; indicating a greater number of ideal
health metrics) would be associated with better cognitive
performance. Furthermore, each metric included in the CHS
would be related to the overall global composite of cognitive
scores.

Procedure
Health factors. Standardised protocols for data collection
were used at all study visits. A blood sample was obtained
following fast from midnight. Standard assay methods were
employed [26] to obtain total cholesterol and fasting plasma
glucose. BP was obtained after a light breakfast. Automated blood
pressure measures (GE DINAMAP 100DPC-120XEN, GE
Healthcare) were taken five times each in reclining, sitting and
standing after a supine rest for 15 minutes, and averaged for
systolic blood pressure (SBP) and diastolic blood pressure (DBP).
Health behaviours. Body weight was measured with participants wearing light clothing to the nearest 0.1 kg, and height was
measured with a vertical ruler to the nearest 0.1 cm. BMI was
calculated as weight in kilograms divided by height in metres
squared. Physical activity was measured with the Nurses’ Health
Study Activity Questionnaire, a validated measure of time spent
engaging in various physical activities [31]. MET-hours per week
for each activity were calculated and summed to give total METminutes per week [32]. Smoking status (never, former, current)
was based on self-report from the Nutrition and Health
Questionnaire [33].
Dietary intake was assessed using the Nutrition and Health
Questionnaire [33]. Participants are required to stipulate how
frequently they consume a list of foods, with six response options
(never, seldom, 1 time per week, 2–4 times per week, 5–6 times per
week, $1 time per day). Portion or serving sizes are not stipulated;
the totals are an estimate of intake in terms of times per day. For
the diet metric, a Recommended Food Score (RFS) [34] and a
non-Recommended Food Score (non-RFS) [35] were calculated,
which differs from the healthy diet metric defined by the AHA.
The RFS included 23 items: four types of fruit, eight types of
vegetables and legumes, five types of wholegrain cereal products,
two types of fish, two low fat milk products, nuts and seeds, and
olive oil. These items are similar to those used previously [34,36].
Consumption of any of the recommended foods at least once per
week was assigned 1 point, otherwise 0 points if consumed less
often [34]. A total RFS out of 23 was calculated, with a high score
indicating a higher consumption of recommended food items.
The non-RFS [35] was calculated as the second aspect of the
diet metric and included 15 items: processed meats, four whole-fat
dairy products, two types of refined grains, solid fats/added sugars
group, and alcohol. A score of 1 was assigned for consumption of
non-recommended foods at least 2 to 4 times per week; otherwise
0 points were assigned if consumed less often than this [36,37]. A
total non-RFS out of 15 was calculated, with a higher value
indicating a higher consumption of non-recommended food items.
Cardiovascular Health Score. Poor, intermediate and ideal
levels for smoking, BMI, physical activity, total cholesterol, blood
pressure, and fasting plasma were determined, based on the AHA
definitions [20]. For each component, participants were given a
score of 1 if they met the ideal AHA criterion, otherwise 0 points
were assigned. Concerning diet, the highest 15% of RFS scores
($14/23) and the lowest 15% of the non-RFS scores (#1/15)
were given a score of 1. Definitions of poor, intermediate and ideal
health for each cardiovascular health component, and the
prevalence of each in the present study can be found in Table
S1. A total CHS was calculated ranging from 0 (no cardiovascular
health metric at ideal levels) to 8 (all cardiovascular health metrics
at ideal levels), and then categorised into low (0–2 metrics at ideal
levels), medium (3–4) or high (5–8) cardiovascular health.

Methods
Ethical Statement
The MSLS was approved by the University of Maine
Institutional Review Board. All participants provided informed
written consent for data collection and medical record review.

Participants
Data were obtained from wave 6 of the Maine-Syracuse
Longitudinal Study (MSLS) [26,27]. At wave 1 MSLS participants
were recruited for studies of blood pressure and cognitive
performance with no recruitment exclusions other than institutionalization, diagnosed psychiatric disorder and alcoholism.
Participants for the present study were those returning for the
sixth (2001–2006) study wave as dietary intake measures were first
obtained at this examination. Details of initial study recruitment
have been previously described [26–29]. Beginning with 1049
individuals, participants were excluded for the following reasons:
missing dietary or cognitive data (n = 34), acute stroke (n = 28),
probable dementia (n = 8), undertaking dialysis treatment (n = 5),
inability to read English (n = 1), and prior alcohol abuse (n = 1).
Acute stroke was defined as a focal neurological deficit persisting
for .24 hours and probable dementia was defined by cognitive
measures, medical records and a multidisciplinary dementia
review using the National Institute of Neurological Diseases and
Communicative Diseases and Stroke/Alzheimer’s Disease and
Related Disorders (NINCDS-ADRDA) criteria [30]. Dementia
cases were excluded as we were interested in examining
relationships between cardiovascular health and cognitive performance, but not in those with severe cognitive impairment. The
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The metrics have not been weighted in the construction of the
CHS as they have been used with equal weights in previous studies
that afford important comparisons with the present study. It has
been established that equal weighting results in scales that are
more robust across studies [38].
Cognitive Function. The MSLS neuropsychological test
battery comprises 20 individual tests designed to measure a wide
range of cognitive abilities, and has been used in multiple studies
examining cardiovascular risk factors and cognitive performance
[26–28]. Prior to this study, these tests were used to derive five
composite scores via factor analysis: Visual-Spatial Memory and
Organization, Scanning and Tracking, Verbal Episodic Memory,
Executive Function, and Working Memory [26]. The WAIS
Similarities Test [39], a measure of abstract reasoning, loaded on
all composite scores (factors) and was thus employed separately.
The tests used to define each composite and the factor analytic
methods used to derive these composites have been described
previously [26]. A Global Cognition Composite score was derived
by averaging the z-scores for all individual tests. In addition, the
MMSE [40], a global measure of mental status widely used in the
literature, is included in the MSLS battery. All cognitive
performance measures are expressed in the same unit of
measurement (SD units).
Covariates. Potential confounding factors were identified on
the basis of two criteria: (1) had to be theoretically relevant [41]
and, (2) had to show a statistically significant association (p,0.05)
with both the CHS and the Global Composite. Covariates
employed in the regression models (described below) were age
(years), education (years), gender, total serves per day of all foods,
depression (Center for Epidemiological Studies Depression Scale,
CES-D, raw score), plasma homocysteine (tHcy, mmol/l), high
sensitivity C-reactive protein (hs-CRP, mg/l), and triglycerides
(mg/dl). Education level was obtained through self-report and
ranged from 4 to 20 years. Total serves per day of all foods was
estimated by summing the total daily intake of all foods included in
the Nutrition and Health Questionnaire. The CES-D [42] was
used to assess depression and the raw score used as a continuous
variable. Plasma tHcy, triglycerides and hs-CRP were determined
from blood samples using standardised MSLS blood sampling
techniques [26].

Associations between each of the eight individual health
behaviors and factors (defined as poor, intermediate, or ideal
according to the AHA) and cognitive function (Global Composite)
were then examined using general linear modelling. The Global
Composite score was selected as the cognitive outcome because it
represents the sum of a wide range of cognitive abilities. Two
covariate sets were employed:
1) Basic covariate set: age, education, gender
2) Full covariate set: Basic + seven other cardiovascular health
components. For example, when assessing BMI and the
Global Composite, the seven remaining health components
(smoking, physical activity, RFS, non-RFS, total cholesterol,
BP, and fasting blood glucose) were included in the model.
Multiple group comparisons were adjusted using the Bonferroni method. The data were plotted as figures. All analyses
were performed using SPSS (version 20; SPSS, Chicago, IL).
Preliminary analyses indicated non-significant interactions
beween age (in years) and the CHS (p.0.06) and between gender
and CHS (p.0.20). Consequently these terms were not included in
the covariate sets described above. Multicollinearity in the two
covariate sets was examined using the variance inflation factor
coefficient and was found to be within acceptable limits (VIF,1.2)
(data not shown).

Results
Sample Characteristics
Table 1 shows the demographic, health and lifestyle factors of
the MSLS participants according to cardiovascular health. Nearly
one-half of participants (48.8%) achieved ideal health on 3 to 4
health metrics. Five or more metrics at ideal levels were achieved
by 13.8% of the sample. Those who met a greater number had a
higher number of education years, fewer depressive symptoms,
and were less likely to be on medications (all p,0.05). They had
significantly lower levels of tHcy, triglycerides, hs-CRP, and
smaller waist circumference (all p,0.01). Mean levels of the health
behaviors and factors were significantly associated with the total
number of ideal health metrics as expected.

Statistical Analysis

Cardiovascular Health Score and Cognition

Initially, descriptive analyses were performed to compare the
demographic, health, and lifestyle characteristics of participants
according to their cardiovascular health using the groups defined
above (low, medium and high).
For the primary analyses, general linear modelling was used to
examine the association between cardiovascular health, indexed
by the CHS (the independent variable), and cognitive function
(dependent variable). The CHS was employed as a categorical
variable. Potential confounding factors were identified as described
above and the following covariate sets were employed:

Associations between the three CHS categories and mean
performance levels for the cognitive composite scores, the Global
Composite, the Similarities test, and the MMSE are shown in
Table 2 (basic and full covariate sets). Cognitive performance
levels increased in a linear fashion for seven out of eight outcomes
as the number of ideal cardiovascular health metrics increased
(exception was for Verbal Memory), with statistical adjustment for
age, education and gender (p,0.05 for linear trend, for all).
Participants with at least five metrics in the ideal range performed
significantly better on Working Memory, Scanning and Tracking,
Executive Function, and on the Global Composite, compared to
those with two or fewer ideal metrics (all p,0.05). When the full
covariate set was employed, significant associations remained
between cardiovasular health and performance on the Global
Composite, Working Memory, and Executive Function (all
p,0.05). No associations were found for the quadratic trend
component (p.0.05).
Sensitivity analyses with the CHS treated as a continuous
variable confirmed the linear trend observed with the categorical
regression analyses. The CHS was positively associated with the
same seven cognitive outcomes (p,0.05 for all, basic covariate set)
(Table S2). With the addition of other cardiovascular and

1) Basic covariate set: age, education, gender
2) Full covariate set: Basic + total serves per day all foods, CESD score, hs-CRP, tHcy, triglycerides.
Analyses of linear and quadratic trends were performed, and
polynomial trend analyses were conducted across the three levels
of cardiovascular health. Adjustments for multiple comparisons
were made and reported in terms of the Bonferroni adjustment.
To confirm our findings, alternative analyses were subsequently
performed using multivariate linear regression, utilising the CHS
as a continuous variable (see Table S2).
PLOS ONE | www.plosone.org
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Table 1. Demographic, health and lifestyle factors of the MSLS sample (N = 972) according to Cardiovascular Health Score.

Cardiovascular Health Score (0–8)
Characteristic

Low CHS 0–2 (n = 364,
37.4%)

Medium CHS 3–4 (n = 474,
48.8%)

High CHS 5–8
(n = 134, 13.8%)

Mean

Mean

Mean

SD

SD

SD

pa

Age (yrs)

62.4

12.6

62.2

13.0

60.7

13.0

0.40

Education (yrs)

14.2

2.7

14.8

2.7

15.4

2.6

,0.001

Smoking (cigarettes smoked/wk in past year)

16.7

47.4

6.1

31.2

1.0

12.1

,0.001

BMI (kg/m2)

31.7

6.2

28.5

5.2

25.6

4.6

,0.001

Physical activity, (MET-hours/wk)

11.1

19.4

24.6

29.4

31.7

31.9

,0.001

Total cholesterol, (mg/dL)

211.2

40.2

198.9

39.1

182.9

31.7

,0.001

SBP (mm Hg)

139.4

18.8

128.5

21.4

115.9

18.9

,0.001

Cardiovascular health metrics

DBP (mm Hg)

73.8

9.63

69.5

9.59

64.8

9.39

,0.001

Fasting blood glucose (mg/dL)

110.1

36.9

93.7

19.9

87.3

9.0

,0.001

RFS (0–23)

9.8

3.0

10.9

2.9

12.0

2.9

,0.001

Non-RFS (0–15)

4.1

1.7

3.6

1.6

2.8

1.8

,0.001

0.001

Additional health variables
HDL-cholesterol (mg/dL)

51.6

14.5

53.9

15.6

57.2

15.4

LDL-cholesterol (mg/dL)

127.2

34.2

120.2

33.1

106.3

25.9

,0.001

Depression (CES-D score)b

8.6

7.4

7.0

6.6

6.8

5.9

0.001

tHcy (mmol/L)

10.2

4.0

10.0

3.5

9.1

2.8

0.008

Waist circumference (cm)

101.2

14.9

93.4

13.9

86.2

13.0

,0.001

Triglycerides (mg/dL)

182.2

153.3

126.4

70.7

95.6

50.0

,0.001

C-reactive protein (mg/dL)

0.52

0.53

0.41

0.48

0.26

0.26

,0.001

Alcohol intake (g/wk)

30.1

68.7

40.7

74.8

35.5

49.1

0.09

Total food serves per day

14.9

4.5

14.8

4.5

14.7

5.2

0.81

Categorical variables

n

%

n

%

n

%

p

Males

141

38.7

203

42.8

55

41.0

Females

223

61.3

271

57.2

79

59.0

Gender

c

0.49

58

15.9

59

12.4

22

16.4

0.27

Diabetes mellitusd

77

21.2

42

8.9

2

1.5

,0.001

Hypertensione

276

75.8

268

56.5

54

40.3

,0.001

Obesity ($30 kg/m2)

183

51.5

165

35.3

21

15.7

,0.001

CVD

Antihypertensive medication

217

59.6

218

46.0

49

36.6

,0.001

Cholesterol-lowering medication

102

28.0

125

26.4

39

29.1

0.77

Diabetes mellitus medication

60

16.5

39

8.2

2

1.5

,0.001

BMI body mass index, CES-D Centre for Epidemiological Studies Depression Scale, CHS Cardiovascular Health Score, CVD cardiovascular disease, DBP diastolic blood
pressure, HDL high-density lipoprotein, hs-CRP high sensitivity C-reactive protein, LDL low-density lipoprotein, MET metabolic equivalent, non-RFS non Recommended
Food Score, RFS Recommended Food Score, SBP systolic blood pressure, SD standard deviation.
a
ANOVA for continuous variables and Chi-square for categorical variables.
b
For CES-D, higher score indicates greater number of depressive symptoms.
c
CVD was defined as present if there was self-reported history of coronary artery disease, myocardial infarction, congestive heart.
failure, transient ischemic attack, or angina pectoris.
d
Diabetes mellitus defined as fasing plasma glucose $126 mg/dL or treated.
e
Hypertension defined as $140/90 mm Hg or treated.
doi:10.1371/journal.pone.0089317.t001

variable from the analyses did not alter the findings (data not
shown).

psychological variables (full covariate set), significant positive
associations remained between CHS and performance on VisualSpatial Memory, Working Memory, Scanning and Tracking,
Executive Function, and the Global Composite (all p,0.05).
There were too few ethnic minority groups to employ ethnicity
in the covariate sets, but exclusion of the ethnic minority group

PLOS ONE | www.plosone.org
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Table 2. Multivariate-adjusted mean and SE for cognitive outcome scores according to Cardiovascular Health Scorec group
(N = 972).

Cognitive outcome measure

Global Composite

Visual-Spatial Memory

Verbal Memory

Working Memory

Scanning Tracking

Executive Function

Similarities

MMSE

Covariate seta

b

Cardiovascular Health Score (0–8)
Low CHS 0–2 (n = 364)

Medium CHS 3–4
(n = 474)

High CHS 5–8 (n = 134)

Mean

Mean

Mean

SE

d

SE

p overall

p linear
trend

SE

d

Basic

20.109

0.041

0.059

0.036

0.131

0.068

0.002

0.003

Full

20.099

0.043

0.053d

0.037

0.090

0.073

0.016

0.030

Basic

20.110

0.044

0.080d

0.038

0.069

0.072

0.003

0.034

Full

20.114

0.046

0.083d

0.039

0.057

0.077

0.005

0.064

Basic

20.055

0.047

0.044

0.041

0.026

0.078

0.28

0.38

Full

20.043

0.050

0.033

0.042

20.003

0.084

0.51

0.68

d

0.081

0.004

0.001

0.088

0.06

0.017

Basic

20.084

0.049

0.009

0.043

0.234

Full

20.066

0.052

20.009

0.044

0.182

Basic

20.086

0.041

0.040

0.036

0.108d

0.067

0.017

0.014

Full

20.070

0.043

0.040

0.036

0.058

0.072

0.10

0.12

Basic

20.071

0.046

0.000

0.040

0.205d

0.076

0.008

0.002

Full

20.06

0.049

20.015

0.041

0.121

0.082

0.18

0.06

Basic

20.077

0.047

0.044

0.041

0.089

0.077

0.08

0.07

Full

20.066

0.050

0.039

0.042

0.051

0.084

0.25

0.24

Basic

20.098

0.049

0.057

0.043

0.110

0.081

0.024

0.029

Full

20.066

0.051

0.049

0.043

0.081

0.086

0.18

0.15

e

BMI body mass index, LDL low density lipoprotein, MMSE Mini-Mental State Examination.
a
Based on 8 health components: smoking, BMI, physical activity, total cholesterol, blood pressure, fasting plasma glucose, 2 dietary indices: Recommended Food Score,
non-Recommended Food Score.
b
Basic covariate set: values are mean z-scores after adjustment for age, education, gender.
c
Full covariate set: values are mean z-scores after adjustment for age, education, gender, total food serves/day, triglycerides, depression, C-reactive protein and total
homocysteine.
d
significantly different from the low group.
e
significantly different from medium group.
doi:10.1371/journal.pone.0089317.t002

subjects in each group, there were fewer subjects in the older
(n = 429) than the younger (n = 543) group. Performance on the
Global Composite increased in a linear fashion as the number of
ideal cardiovascular health metrics increased for both age groups.
For those aged under 60 years, the multivariate adjusted mean zscore and 95% CI, for those with the lowest CHS (0–2) was 0.273
(95% CI = 0.169–0.379), compared with a mean of 0.585 (95%
CI = 0.419–0.750) for those with a CHS between 5 and 8
(p = 0.006), with statistical adjustment for age, education and
gender. In general, effect sizes and differences among means were
smaller for the older group but the pattern of results for the
younger versus older participants was the same. For those aged 60
years or more, those with a CHS of 0–2 had a mean Global
Composite z-score of 20.594 (95% CI 20.719–20.469),
compared to those in the highest CHS category with a mean
score of 20.474 (95% CI = 20.691–20.257), p = 0.056.

health are shown in Figure 1. The Global Composite score
increased significantly as health levels increased from poor to ideal,
for smoking, BMI, and physical activity (p for linear trend ,0.05,
for all). This was true with adjustment for age, education, and
gender. Athough not statistically significant, Global Composite
scores were also the highest for those with ideal cardiovascular
health levels on the two diet scores. With full adjustment for the
other cardiovascular health components, positive associations
remained for smoking and physical activity (data not shown).
Health factors. Mean Global Composite z-scores for each
health factor (total cholesterol, blood pressure, and fasting plasma
glucose) according to cardiovascular health level are shown in
Figure 2. There was a positive association between the Global
Composite score and health level for BP and fasting blood glucose
(p for linear trend ,0.05, for both). With full adjustment, positive
associations remained for fasting plasma glucose (data not shown).
Total cholesterol displayed a significant inverse relationship with
cognitive performance (p for linear trend ,0.05, for both covariate
sets).

Discussion
In this community-based study of adults, a greater number of
ideal cardiovascular health components (a higher CHS) was
positively associated with neropsychological test performance on a
range of cognitive domains. Visual-Spatial Memory, Working
Memory, Scanning and Tracking, Executive Function and Global
composite scores were associated with higher CHS, and this was
true with adjustment for demographic variables, cardiovascular
risk factors and psychological variables. The fact that multiple

A Posteriori Examination of CHS x Age Interactions
As a final check on the possibility of age interactions with CHS
in relation to the cognitive variables, a posteriori analysis was done
comparing younger and older age groups, with the former defined
as individuals under 60 years of age and the latter aged 60 years or
more. Despite using age groups that maximized the number of
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Figure 1. Mean Global Cognition Composite scores according to cardiovascular health level for each health behavior. Scores are
mean Global Composite z-scores (and standard errors) for poor, intermediate and ideal health categories for smoking, BMI, physical activity,
Recommended Food Score, and the non-Recommended Food Score, adjusted for age, education and gender. p-values are for significant linear
trends.
doi:10.1371/journal.pone.0089317.g001

Tracking, Executive Function, and on the Global Composite, as
compared to those with two or fewer ideal metrics.
In a broader framework these results extend work done with the
Framingham Heart Study in which the Framingham Stroke Risk
Profile, a combination of weighted cardiovascular risk factors were
related to lower cognitive performance on several individual
measures [14]. However, the Framingham Scale includes risk
factors, but does not include other health behaviors such as diet. It
emphasizes risk factors that predict stroke, while the AHA-based
scale used in this study emphasizes the attainment of ideal levels of
risk factors. In comparison with the CAIDE dementia risk scale,
the AHA scale also includes diet, and the physical activity criteria
are more stringent; ideal health for physical activity is the
attainment of at least 150 minutes of moderate activity per week
[20], compared with 40–60 minutes per week in the CAIDE risk
scale [17]. Both the Framingham stroke and CVD risk scores and
the CAIDE dementia score have been shown to predict cognitive
decline in late middle age [15].
The importance of the inclusion of behavioral factors in addition
to traditional CVD risk factors was demonstrated in this study.
Positive linear associations between each of the health behaviors
(non-smoking, engaging in physical activity, maintaining a normal
BMI, consuming more recommended foods) and Global cognitive
performance were observed (although statistical significance was not

cognitive functions were associated with CHS suggests that high
levels of health have a generalized association with cognitive
function.
Less than 1% of the sample (0.6%) achieved ideal health on
seven or eight metrics. This is consistent with other US data, with
studies reporting similarly very low prevalences, ranging from 0–
0.1% [43–45] to 1.2% [46]. In 2007 to 2008, virtually no children
in the USA meet all seven criteria for ideal cardiovascular health,
while most adults (60%) had 2, 3, or 4 criteria at ideal levels [45].
In the present study, 71% had between 2 and 4 components at
ideal levels. What is of greatest concern is the national data
indicating that the prevalence of ideal cardiovascular health
actually decreased from 2.0% in 1988–1994 to 1.2% in 2005–
2010 [46].
The present results extend and refine findings from the
CARDIA study [23]. In the CARDIA study, multiple metrics of
ideal cardiovascular health in young adults (18 to 30 years) were
positively associated with better performance on tests of psychomotor speed, executive function and verbal domains up to 25 years
later. More specifically, CARDIA participants who had at least
five ideal cardiovascular health metrics over the study period had
better cognitive performance on all three tests. In the present
investigation, participants with at least five metrics in the ideal
range performed better on Working Memory, Scanning and
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Figure 2. Mean Global Cognition Composite scores according to cardiovascular health level for each health factor. Scores are mean
Global Composite z-scores (and standard errors) for poor, intermediate and ideal health categories for total cholesterol, blood pressure, and fasting
plasma glucose, adjusted for age, education and gender. p-values are for significant linear trends.
doi:10.1371/journal.pone.0089317.g002

cigarette smoke contribute to the development of atherosclerosis,
the main underlying pathophysiologic process of CVD and its
clinical manifestations, as well as inducing a systemic inflammatory
response [58,59].
In the present study, participants with ideal levels for total
cholesterol had significantly lower scores on global cognition
measures (p,0.001 for both covariate sets). While this may seem
counter to the expectation that ideal levels would result in better
cognitive performance, positive associations between total serum
cholesterol and cognition have been previously reported [60,61].
The adverse effects of low serum cholesterol on cognitive
performance have biologic plausibility as neuronal cells require
cholesterol for normal metabolic processes, and cholesterol is
important for brain development and maintenance of brain
function [62].
Limitations include the use of self-reported measures of diet and
physical activity, measured at one point in time, which may not
accurately reflect long-term patterns. The study is cross-sectional,
which prevents any conclusions regarding causality to be made.
An acknowledged limitation is the lack of a caloric measure of total
energy intake, which was unable to be obtained from the
questionnaire used. This was therefore estimated using total daily
serves of all foods from the dietary questionnaire. Finally, the

reached for diet). Blood glucose levels and BP were inversely related
to the Global Composite score. Reviews of the literature indicate
that BP, diabetes, smoking, hypertenson and obesity are major risk
factors for cognitive performance [7]. SBP, hypertension, diabetes,
cigarette smoking status, history of CVD, atrial fibrilation, and left
ventricular hypertrophy were all associated with lower levels of
cognitive performance for multiple cognitive domains in the
Framingham Heart Study [1,47–49] as was the overall risk factor
score. Thus our findings with respect to the individual risk factors
are consistent with the literature.
As obesity places an individual at greater risk for type 2 diabetes,
hypertension and elevated blood lipid concentrations [50], and
may exacerbate cognitive decline in those with poorer cardiometabolic health [51,52], it is a key component of cardiovascular
health. The high levels of obesity (38% with BMI$30 kg/m2) and
physical inactivity in the present study sample are alarming. At
least 150 minutes per week of moderate intensity physical activity
was not achieved by 44% of participants. Time spent sedentary
has been associated with poorer cardiometabolic biomarkers [53],
metabolic syndrome [54], and CVD [55]. Increasing cardiovascular fitness may result in improved vascular health and increase
brain tissue perfusion, which may result in cognitive gains [56,57].
The evidence for the adverse effects of smoking on health are
overwhelming; the toxic products added to the bloodstream from
PLOS ONE | www.plosone.org

7

March 2014 | Volume 9 | Issue 3 | e89317

Cardiovascular Health and Cognitive Function

limited number of older participants in the present study limits the
generalizability of the findings.
There are a number of strengths and unique aspects to this
study. Firstly, we utilized a community-based sample with
extensive data on cardiovascular risk factors providing the metrics
needed to calculate the CHS. Secondly, we examined multiple
cognitive domains (composite scores), each indexed by multiple
tests of cognitive ability as determined by previous factor analyses
[26]. Therefore, the present study is the first to have assessed the
combined effect of multiple cardiovascular risk factors on global
cognition and multiple cognitive domains taken from an extensive
neuropsychological test battery. Thirdly, a different measure of a
healthful diet than that defined by the AHA and used in CARDIA
[23] was implented. The AHA diet metric is based on achieving
recommended intakes of fruit and vegetables, fish, high-fiber
whole grains, and minimising intakes of sodium and sugarsweetened beverages [20]. Given the growing evidence for the role
that diet may play in cognitive function [2,3,63], the healthy diet
score as defined by the AHA was expanded so as to include intake
of a greater number of foods in line with the current national
guidelines [64] and to obtain a greater indication of dietary
variety. Fourthly, a wide age range including middle-aged and
elderly participants was used. However there were no interactions
between age (continously distributed) and cognitive performance,
which suggests the findings extend to older groups beyond the
young to middle-aged adults examined in CARDIA. Further
inspection and analysis of results for persons over and under 60
years of age were highly similar in terms of differences among
means for all composite scores with some reduction in magnitude
of effect for the older individuals and a marginal p value for the
older groups. There are several possible reasons for this finding.
Sample size was smaller in the older group (429 versus 543), we
excluded older persons with dementia, acute stroke and on
dialysis, and the MSLS sample exhibites a very low level of
cardiovascular events and CVD despite the presence of risk
factors. Moreover, this finding is consistent with previous crosssectional research in which associations between hypertension and
cognition were stronger in young and early middle age than in
older individuals [65,66] and may be due to the fact that persons
who do less well do not survive into old age or self-select out of
cross-sectional studies. In the context of this literature and the
characteristics of our sample, absence of age interactions with
respect to relations between CHS and cognitive performance
make logical sense. These relations are best examined in the
context of longitudinal designs. Future studies focusing on specific
age groups are needed. Finally, following recommendations for
future research in a previous paper [67] we examined relations
between the individual cardiovascular metics and cognitive
outcomes.

Conclusions
A higher CHS, indexed by risk factors, lifestyle factors and
health measures, was associated with performance on multiple
cognitive domains and global cognitive function. With control for
other cardiovascular and psychological factors, this association
remained significant for the Global Composite,Visual-Spatial
Memory, Working Memory, Scanning and Tracking, and
Executive Function composite scores. Ideal health scores for
smoking, BMI, physical activity, BP, and fasting blood glucose
were all positively associated with the Global Composite score. As
has been previously reported [43–46], relatively few study
participants met the AHA definition of ideal cardiovascular health
in the present study.

Implications
The personal and financial burden of cognitive decline and
dementia, in terms of medical costs, quality of life and productiveyears lost, are significant [25]. The AHA 2020 goals of improving
health behaviors and reducing preventable cardiovascular risk
factors gains support from the present study. However, by virute of
the design we are unable to separate casue and effect relations.
Those with better cognitive performance may engage in better
health behaviors. However, it is clear from our observational data
that better cardiovascular health and improved cognition are
associated. Longitudinal analyses and eventally clinical trials will
be necessary to clarify the direction of these associations.
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